Abstract | BACKGROUND AND AIMS: METHODS AND RESULTS: We demonstrate that clofibrate induces HO-1 expression in a concentration- and time-dependent manner. The induction of HO-1 by clofibrate was detected at both mRNA and protein levels and the HO-1 gene promoter activity was also dramatically induced by clofibrate, indicating that clofibrate up-regulates HO-1 gene transcription. Surprisingly, the induction of HO-1 by clofibrate was mediated by the Nrf2 signaling pathway, not by the PPARα pathway. This was primarily demonstrated by siRNA knockdown of Nrf2 expression that significantly attenuated clofibrate-induced HO-1 gene transcription, and siRNA knockdown of PPARα that had no effect on clofibrate-induced HO-1 promoter activity. Furthermore, deletion of the antioxidant response elements (AREs) in the HO-1 gene promoter diminished clofibrate-induced HO-1 transcription and deletion of the PPAR response elements (PPREs) had no such effect. Likewise, application of PPARα antagonists had no effect on clofibrate-induced HO-1 expression. CONCLUSION:
Clofibrate induces HO-1 gene expression in cancer cells through a PPARα-independent mechanism and the Nrf2 signaling pathway is indispensible for this induction.
|
Authors | Shuai Wang, Bethany N Hannafon, Jundong Zhou, Wei-Qun Ding |
Journal | Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
(Cell Physiol Biochem)
Vol. 32
Issue 5
Pg. 1255-64
( 2013)
ISSN: 1421-9778 [Electronic] Germany |
PMID | 24247298
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2013 S. Karger AG, Basel. |
Chemical References |
- NF-E2-Related Factor 2
- NFE2L2 protein, human
- PPAR alpha
- HMOX1 protein, human
- Heme Oxygenase-1
- Clofibrate
|
Topics |
- Cell Line, Tumor
(drug effects)
- Clofibrate
(pharmacology)
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- Heme Oxygenase-1
(genetics)
- Humans
- Male
- NF-E2-Related Factor 2
(genetics, metabolism)
- Ovarian Neoplasms
(drug therapy, genetics, metabolism)
- PPAR alpha
(genetics, metabolism)
- Promoter Regions, Genetic
- Prostatic Neoplasms
(drug therapy, genetics, metabolism)
- Response Elements
(drug effects)
- Signal Transduction
(drug effects)
|